A new study has revealed large differences in attitudes toward various types of drugs, with a growing acceptance of psychedelics and strong negative feelings toward more traditional illicit drugs.

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...